VEGFA and Stroke: These new techniques are currently applied to animal studies but as shown in clinical trials of adeno-associated virus for PD [53,54], pro-VEGF therapy using viral vectors as a clinically applicable optional treatment in cerebrovascular diseases including stroke and post-stroke hydrocephalus should be further developed.